Benzinga's Top #PreMarket Losers

By: via Benzinga
Eleven Biotherapeutics Inc (NASDAQ: EBIO) slipped 74.94 percent to $3.00 in pre-market trading after the company reported top-line ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.